This week, there are 9 drugs in the patent and exclusivity list. They are: - AFT PHARMACEUTICALS US INC's COMBOGESIC, containing active ingredient ACETAMINOPHEN; IBUPROFEN - ACADIA PHARMACEUTICALS INC's NUPLAZID, containing active ingredient PIMAVANSERIN TARTRATE - NOVARTIS PHARMACEUTICALS CORP's TASIGNA, containing active ingredient NILOTINIB HYDROCHLORIDE - SECURA BIO INC's COPIKTRA, containing active ingredient DUVELISIB - UCB INC's FINTEPLA, containing active ingredient FENFLURAMINE HYDROCHLORIDE - PFIZER INC's VIZIMPRO, containing active ingredient DACOMITINIB - HARROW EYE LLC's IHEEZO, containing active ingredient CHLOROPROCAINE HYDROCHLORIDE - JAZZ PHARMACEUTICALS RESEARCH UK LTD's EPIDIOLEX, containing active ingredient CANNABIDIOL - INSMED INC's ARIKAYCE KIT, containing active ingredient AMIKACIN SULFATE

This week, there are 2 drugs in the patent and exclusivity list. They are: - CURRAX PHARMACEUTICALS LLC's ONZETRA XSAIL, containing active ingredient SUMATRIPTAN SUCCINATE - FENNEC PHARMACEUTICALS INC's PEDMARK, containing active ingredient SODIUM THIOSULFATE

This week, there are 6 drugs in the patent and exclusivity list. They are: - GERON CORP's RYTELO, containing active ingredient IMETELSTAT SODIUM - MYLAN SPECIALTY LP's EPIPEN JR., containing active ingredient EPINEPHRINE - MYLAN SPECIALTY LP's EPIPEN, containing active ingredient EPINEPHRINE - BAUSCH AND LOMB INC's PROLENSA, containing active ingredient BROMFENAC SODIUM - EISAI INC's HALAVEN, containing active ingredient ERIBULIN MESYLATE - MERIDIAN MEDICAL TECHNOLOGIES LLC's SEIZALAM, containing active ingredient MIDAZOLAM HYDROCHLORIDE

This week, there are 10 drugs in the patent and exclusivity list. They are: - SUCAMPO PHARMA AMERICAS LLC's AMITIZA, containing active ingredient LUBIPROSTONE - GENENTECH INC's ERIVEDGE, containing active ingredient VISMODEGIB - GE HEALTHCARE's VIZAMYL, containing active ingredient FLUTEMETAMOL F-18 - AVERITAS PHARMA INC's QUTENZA, containing active ingredient CAPSAICIN - BOEHRINGER INGELHEIM PHARMACEUTICALS INC's PRADAXA, containing active ingredient DABIGATRAN ETEXILATE MESYLATE - BAYER HEALTHCARE PHARMACEUTICALS INC's KERENDIA, containing active ingredient FINERENONE - VERTEX PHARMACEUTICALS INC's ORKAMBI, containing active ingredient IVACAFTOR; LUMACAFTOR - CURIUM US LLC's DETECTNET, containing active ingredient COPPER CU-64 DOTATATE - RIGEL PHARMACEUTICALS INC's GAVRETO, containing active ingredient PRALSETINIB - ASTELLAS PHARMA US INC's CRESEMBA, containing active ingredient ISAVUCONAZONIUM SULFATE

This week, there are 5 drugs in the patent and exclusivity list. They are: - GALDERMA LABORATORIES LP's MIRVASO, containing active ingredient BRIMONIDINE TARTRATE - PF PRISM CV's XALKORI, containing active ingredient CRIZOTINIB - ALNYLAM PHARMACEUTICALS INC's GIVLAARI, containing active ingredient GIVOSIRAN SODIUM - INCYTE CORP's PEMAZYRE, containing active ingredient PEMIGATINIB - SUN PHARMACEUTICAL INDUSTRIES LTD's WINLEVI, containing active ingredient CLASCOTERONE

This week, there are 10 drugs in the patent and exclusivity list. They are: - SPRINGWORKS THERAPEUTICS INC's OGSIVEO, containing active ingredient NIROGACESTAT HYDROBROMIDE - VERO BIOTECH INC's GENOSYL, containing active ingredient NITRIC OXIDE - CURRAX PHARMACEUTICALS LLC's ONZETRA XSAIL, containing active ingredient SUMATRIPTAN SUCCINATE - SANDOZ INC's QOLIANA, containing active ingredient BRIMONIDINE TARTRATE - UNITED THERAPEUTICS CORP's TYVASO DPI, containing active ingredient TREPROSTINIL - CUMBERLAND PHARMACEUTICALS INC's ACETADOTE, containing active ingredient ACETYLCYSTEINE - AXSOME THERAPEUTICS INC's AUVELITY, containing active ingredient BUPROPION HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE - BIOCODEX SA's DIACOMIT, containing active ingredient STIRIPENTOL - PHARMACYCLICS LLC's IMBRUVICA, containing active ingredient IBRUTINIB - BOEHRINGER INGELHEIM PHARMACEUTICALS INC's JARDIANCE, containing active ingredient EMPAGLIFLOZIN

This week, there are 6 drugs in the patent and exclusivity list. They are: - NOVO NORDISK INC's OZEMPIC, containing active ingredient SEMAGLUTIDE - NOVO NORDISK INC's VICTOZA, containing active ingredient LIRAGLUTIDE - NOVO NORDISK INC's SAXENDA, containing active ingredient LIRAGLUTIDE - NIPPON SHINYAKU CO LTD's VILTEPSO, containing active ingredient VILTOLARSEN - VERTEX PHARMACEUTICALS INC's KALYDECO, containing active ingredient IVACAFTOR - EISAI INC's LENVIMA, containing active ingredient LENVATINIB MESYLATE

This week, there are 9 drugs in the patent and exclusivity list. They are: - BRISTOL MYERS SQUIBB CO's SPRYCEL, containing active ingredient DASATINIB - GILEAD SCIENCES INC's ZYDELIG, containing active ingredient IDELALISIB - SUMITOMO PHARMA SWITZERLAND GMBH's MYFEMBREE, containing active ingredient ESTRADIOL; NORETHINDRONE ACETATE; RELUGOLIX - BAYER HEALTHCARE PHARMACEUTICALS INC's NUBEQA, containing active ingredient DAROLUTAMIDE - BAYER HEALTHCARE PHARMACEUTICALS INC's LAMPIT, containing active ingredient NIFURTIMOX - VERTEX PHARMACEUTICALS INC's ORKAMBI, containing active ingredient IVACAFTOR; LUMACAFTOR - GENENTECH INC's EVRYSDI, containing active ingredient RISDIPLAM - ALNYLAM PHARMACEUTICALS INC's ONPATTRO, containing active ingredient PATISIRAN SODIUM - AMICUS THERAPEUTICS US LLC's GALAFOLD, containing active ingredient MIGALASTAT HYDROCHLORIDE

This week, there are 4 drugs in the patent and exclusivity list. They are: - GILEAD SCIENCES INC's LIVDELZI, containing active ingredient SELADELPAR LYSINE - ABBVIE INC's KYBELLA, containing active ingredient DEOXYCHOLIC ACID - GENENTECH INC's COTELLIC, containing active ingredient COBIMETINIB FUMARATE - ARCUTIS BIOTHERAPEUTICS INC's ZORYVE, containing active ingredient ROFLUMILAST